Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
6.80
+0.52 (8.28%)
May 13, 2025, 4:00 PM - Market closed
Forte Biosciences Employees
Forte Biosciences had 14 employees as of December 31, 2024. The number of employees increased by 5 or 55.56% compared to the previous year.
Employees
14
Change (1Y)
5
Growth (1Y)
55.56%
Revenue / Employee
n/a
Profits / Employee
-$2,534,143
Market Cap
44.76M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
FBRX News
- 6 weeks ago - Forte Biosciences, Inc. Announces Results and Provides Clinical Update - Business Wire
- 3 months ago - Forte Biosciences, Inc. to Present at Upcoming Investor Meetings - Business Wire
- 6 months ago - Forte Biosciences to Host R&D Day December 3, 2024 - Business Wire
- 6 months ago - Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications - Business Wire
- 6 months ago - Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update - Business Wire
- 9 months ago - Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update - Business Wire
- 1 year ago - Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - Business Wire
- 1 year ago - Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update - Business Wire